WFDC2 and pancreatitis: Better use of existing predictors (sequence tests, combined tests, or artificial neural network methods) is promising unless there is a new biomarker that ultimately reveals disease severity.25 In our study, we used HE4, a biomarker that we can measure its concentration in the blood, to show the severity of pancreatitis.